The gain and loss of function experiments demonstrated that ALDH2 inhibited HCC cell migration and invasion both in vitro and in vivo by modulating the redox status of cells and by activating the AMP-activated protein kinase (AMPK) signaling pathway [41]. Here, ALDH2 is linked to hepatocellular carcinoma.